PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clínica Zabala. ruxopublication@protonmail.com.\', \'Clínica Zabala, Swiss Medical Group, Buenos Aires. drjoaquincastro@gmail.com.\', \'Clínica Zabala, Swiss Medical Group, Buenos Aires. edgardoge@gmail.com.\', \'Clínica Zabala, Swiss Medical Group, Buenos Aires. caroletti23@gmail.com.\', \'Clínica Zabala, Swiss Medical Group, Buenos Aires. SilvioP@swissmedical.com.ar.\', \'Clínica Zabala, Swiss Medical Group, Buenos Aires. mcuesta@intramed.net.\', \'Clínica Zabala, Swiss Medical Group, Buenos Aires. Pablo.Gutierrezfernandez@swissmedical.com.ar.\', \'Hospital General de Agudos \'Parmenio Piñero\', Buenos Aires. araceli_mandrile@hotmail.com.\', \'Hospital General de Agudos \'Parmenio Piñero\', Buenos Aires. Dra.apcontreras2326@yahoo.com.\', \'Hospital General de Agudos \'Parmenio Piñero\', Buenos Aires. sebagerva@gmail.com.\', \'. gverde@hotmail.com.\', \'Sanatorio Allende, Córdoba. cgalletti21@gmail.com.\', \'Sanatorio Allende, Córdoba. estefaniaminoldo@hotmail.com.\', \'Hospital General de Agudos \'Parmenio Piñero\', Buenos Aires. vanesacaruso060974@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.31053/1853.0605.v78.n3.32800
?:doi
?:hasPublicationType
?:journal
  • Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)
is ?:pmid of
?:pmid
?:pmid
  • 34617700
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Ruxolitinib in severe COVID-19: Results of a multicenter, prospective, single arm, open-label clinical study to investigate the efficacy and safety of ruxolitinib in patients with COVID-19 and severe acute respiratory syndrome
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all